. Analysis of HER2-TTC by SEC-HPLC upon storage. HER2-TTC was radiolabeled at a specific activity of 2 kBq/µg at an radioactive concentration of 2 MBq/ml and stored at room temperature. At t = 0 and 48 h, aliquots were analyzed by SEC-HPLC. Absorbance at UV 280 nm served to monitor changes in monomer levels (A, B) . Similarly, radio-HPLC (C, D) served to monitor changes in monomer levels in the radiolabeled fraction of HER2-TTC.
% IA/g Th-227 Figure S2 . Tumor uptake and retention in DLD-1 BRCA2 -/-compared to DLD-1 Parental. Percentage of injected activity of thorium-227 per gram (% IA/g) in DLD-1 parental and DLD-1 BRCA2 -/-tumors after a single treatment with HER2-TTC (600 kBq/kg). The % IA/g was not significantly different between the models at any of the the timepoints. Figure S4 . Body weights of DLD-1 parental or DLD-1 BRCA2-/-bearing mice. Body weight in mice with A) DLD-1 parental xenograft and B) DLD-1 BRCA2 -/-xenograft bearing mice after a single dose administration of HER2-TTC (120, 300 or 600 kBq/kg, 0.14 mg/kg, i.v.) and olaparib (25 or 50 mg/kg daily for four weeks) as monotherapies or in combination treatment as compared to vehicle. A B Table S1 . Radiostability of HER2-TTC over the course of 48 hours at room temperature. HER2-TTC was radiolabeled at a specific activity of 2 kBq/µg at and a radioactive concentration of 2 MBq/ml.
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